Clinical Trials Directory

Trials / Completed

CompletedNCT01698450

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

MR-Guided Functional Ultrasound-Neurosurgery for Movement Disorders

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to asses the efficacy and the clinical safety of the transcranial magnetic resonance guided high intensity focused ultrasound system ExAblate 4000, InSightec Ltd. for functional neurosurgery in the treatment of movement disorders. The treatments to be conducted in this study are non-invasive, i.e. without opening the skull, and will create microthalamotomies in specific target areas such as thalamus, subthalamus and pallidum. The data obtained in this study will be used to evaluate the basic safety aspects of this new treatment technology and will serve as a basis for the clinical introduction of MR-guided ultrasound neurosurgery.

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive intervention with focused ultrasound (ExAblate 4000)Non-invasive brain intervention using MR-guided focused ultrasound

Timeline

Start date
2012-11-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-10-03
Last updated
2014-10-09

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01698450. Inclusion in this directory is not an endorsement.

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders (NCT01698450) · Clinical Trials Directory